Display options
Cite
Sobel M. Commentary. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Perspect Vasc Surg Endovasc Ther. 2007;19(1):87-9doi: 10.1177/1531003507299489.
Sobel, M. (2007). Commentary. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Perspectives in vascular surgery and endovascular therapy, 19(1), 87-9. https://doi.org/10.1177/1531003507299489
Sobel, Michael. "Commentary. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial." Perspectives in vascular surgery and endovascular therapy vol. 19,1 (2007): 87-9. doi: https://doi.org/10.1177/1531003507299489
Sobel M. Commentary. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Perspect Vasc Surg Endovasc Ther. 2007 Mar;19(1):87-9. doi: 10.1177/1531003507299489. PMID: 17437989.
Copy Download .nbib Format: NLM
Share it on

Perspect Vasc Surg Endovasc Ther. 2007 Mar;19(1):87-9. doi: 10.1177/1531003507299489.

Commentary. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.

Perspectives in vascular surgery and endovascular therapy

Michael Sobel

Affiliations

  1. University of Washington School of Medicine, Seattle, Washington, USA.

PMID: 17437989 DOI: 10.1177/1531003507299489

[No abstract available.]

Publication Types